MedTrace Logo

C-reactive Protein Levels Among Individuals With COVID-19

NCT04373798 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1006

Last updated 2021-08-18

No results posted yet for this study

Summary

The primary objective of this multi-center study is to clarify the value of a CRP measurement for triage of patients initially presenting with light symptoms of the COVID-19 infection.

Current recommendations of management of COVID-19 include large-scale tests for virus. Such tests reveal whether an individual is infected with the virus, however, the demonstration of virus per se has no prognostic value for the ensuing course of the COVID-19 disease. Publications of possible treatments strategies increase exponentially, while evidence of triage of the affected individuals is mainly based on the level of pulmonary affection as measured by the Oxygen saturation.

To inform decision making for which patients are to be hospitalized due to risk of developing more severe affection, this study addresses the question, whether triage may be performed with the aid of a simple CRP measurement.

Conditions

  • Coronavirus Infection

Interventions

DIAGNOSTIC_TEST

C-reactive protein

Measurement of CRP value from blood sample taken at covid19 check point (baseline).

Sponsors & Collaborators

  • Henning Bliddal

    lead OTHER

Principal Investigators

  • Henning Bliddal, DMSc · The Parker Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-04
Primary Completion
2020-08-30
Completion
2021-03-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04373798 on ClinicalTrials.gov